Acute Heart Failure (AHF) Therapeutics Market - Size, Share, Outlook, and Forecast till 2026

Acute heart failure (AHF), also known as acute decompensated heart failure or cardiac failure, is a clinical syndrome that is associated with a wide range of symptoms such as dyspnoea, orthopnoea, and lower limb swelling. Acute heart failure is the inability of the heart to pump blood at a normal rate so as to serve the needs of the body.

Acute heart failure is primary caused due to disturbance in the systolic or diastolic heart function and may also be a result of abnormal venous or arterial vasoconstriction and volume overload. Some other factors causing acute heart failure include allergic reactions, blood clot in the lungs, complication resulting from cardiopulmonary bypass surgeries, heart attacks, severely irregular heartbeats, and virus attacking the heart.

Research has been conducted over the recent past to develop effective therapies for acute heart failure. Some of the major therapies developed for treatment of this disease include Beta blockers, Clevidipine, and Sodium nitroprusside class of drugs.

Beta blockers are beta-adrenergic blocking agents, which help reduce blood pressure by blocking the release of hormone adrenaline. This class of drug helps slow down heart beats, thereby reducing blood pressure and improving blood flow. CLEVIPREX, also known as clevidipine, is a dihydropyridine calcium channel blocker specifically used to reduce blood pressure, in cases when oral therapy cannot be provided or has no effect.

According to American Heart Association (AHA), 2018, the prevalence of heart failure is increasing among the aging population and is estimated at 6.5 million adults. The major risk factors for HF are CHD, hypertension, and diabetes. The increasing prevalence of heart failure, in turn, is expected to increase the demand for therapeutics or drugs to treat this condition. Thus, the acute heart failure therapeutics market is expected to witness significant growth in the near future.

Growing urbanization coupled with increasing inclination towards sedentary lifestyle in turn, is increasing prevalence of diabetes. This is increasing the risk of acute heart failure among the diabetic population, which in turn, is increasing the demand for treatment of such a condition. This in turn, is boosting growth of the acute heart failure therapeutics market.

Some therapies for treatment of acute heart failure are associated with side effects such as fatigue, cold hands or feet, and weight gain, which in turn, pose as major factors restraining growth of the acute heart failure therapeutics market.

Major players operating in the global acute heart failure therapeutics market include Pfizer, GlaxoSmithKline plc. Novartis International AG, Biovail, Bristol Mayers Squibb Company, MSD, AstraZenica, Abiomed Inc., Symplmed, Berlin Heart GmbH, and Biotronik SE & Co. KG.

In March 2013, Pfizer Inc. announced results from the REMINDER trial for its new drug INSPRA, which shows significant reductions in risk for acute heart failure. INSPRA is a steroid nucleus-based mineralcorticoid receptor (MR) antagonist with a higher degree of selectivity than spironolactone. This drug is indicated for use in patients suffering from left ventricular (LV) systolic dysfunction and congestive heart failure after an acute myocardial infarction.

Report includes chapters which deeply display the following deliverable about industry:

• Acute Heart Failure (AHF) Therapeutics Market Research Objective and Assumption
• Acute Heart Failure (AHF) Therapeutics Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM)
• Acute Heart Failure (AHF) Therapeutics Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Acute Heart Failure (AHF) Therapeutics Market, By Regions
• Acute Heart Failure (AHF) Therapeutics Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Acute Heart Failure (AHF) Therapeutics Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors.
• Acute Heart Failure (AHF) Therapeutics Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change.
• Acute Heart Failure (AHF) Therapeutics Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion

Global Peptide Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood t...

Global Heart Lung Machine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Heart Lung Machine is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the "pump", and does the work of the heart and lungs during the operation. Scope of the Report: He...

Global Plasma Protein Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product...

Global Infantile Spasms Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmi...

Global Acute Care Needleless Connector Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Acute Care Needleless connectors are utilized to connect catheters to syringes or IV systems and acute care needleless connectors allow the easy administration of medicines as well as convenient withdrawal of blood intravenously. Scope of the Report: In the last several years, Glo...

Global Artificial Heart Lung Machines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the "pump", and does the work of the heart and lungs during the operation. Scope of the Repo...

Global Pruritus Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral res...

Global Microbiome Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a to...

Global Sarcoma Therapeutics Market Research Report 2019

Published Date : Jan 2019

Sarcoma Therapeutics Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, G...

Global Neurodegenerative Diseases Therapeutics Market Research Report 2019

Published Date : Jan 2019

Neurodegenerative Diseases Therapeutics Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countrie...

 

Select License :

  • Single User : $4500
  • Multiple User : $7000
  • Corporate User : $10000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.